Indication
Hematologic Malignancies
The Hematologic Malignancies pipeline: 3 tracked drugs.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Hematologic Malignancies, so this list is not complete.
1 Phase 12 preclinical / unstaged
Compare the share prices of listed companies in Hematologic Malignancies →
Market size not yet sourced. How markets are sized ↗